Delivery Order SPE2DB24D1021-SPE2DB25FEUTC

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the specialty medication KISQALI (400 mg daily dose, 42 tablets) and has a ceiling value of $20,993.59. The contract is firm fixed price and runs through May 16, 2024. This IDC serves as a primary vehicle for providing a...
This federal contract award, valued at $12,102.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $68,334.56 firm fixed-price contract is for the delivery of KISQALI 400 MG DAILY DOSE 42S, a medical product, with a completion date of December 14, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,749.66, is a delivery order for the supply of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product. The contract has a completion date of May 9, 2024 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,406.93, is for the delivery of KISQALI 400 MG DAILY DOSE 42S, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,553.54, is a Firm Fixed Price Delivery Order for the delivery of the pharmaceutical product KISQALI 600 MG DAILY DOSE 63S. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,716.15 Firm Fixed Price delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $27,417.90, is for the delivery of KISQALI 400 MG DAILY DOSE 42S pharmaceutical products. The contract has a completion date of March 11, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,671.58 Firm Fixed Price delivery order is for the supply of 4566205576 - KISQALI 400 MG DAILY DOSE 42S, a specialty medication. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $20,581.60 firm-fixed price contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a specialty medication. This is not a set-aside contract. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEUTC
    Delivery Order

This is a delivery order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,389.77, is for the delivery of KISQALI 400 MG DAILY DOSE 42S, a specialty pharmaceutical product, to support federal healthcare programs. This contract is part of Amerisourcebergen's larger $999,999,999 IDC with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 6/9/25, 9:46 AM